← Browse by Condition
Medical Condition
cutaneous squamous cell carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT05076760 Phase 1
Recruiting
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
Memgen, Inc.
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Enrollment
292 pts
Location
United States, Austr...
Sponsor
Bicara Therapeutics